Incorporating camptothecins into a multivalent, polymer-based prodrug can overcome resistance in high-risk solid tumors and reduce toxicities, researchers found in preclinical experiments.
Reuters Health Information
Incorporating camptothecins into a multivalent, polymer-based prodrug can overcome resistance in high-risk solid tumors and reduce toxicities, researchers found in preclinical experiments.
Reuters Health Information